ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2021

[Clinical efficacy of anlotinib plus S-1 as a second-line therapy for recurrent or metastatic esophageal squamous cell carcinoma].

W Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.